Ducharme is a contributor to TIME. Travelers walk through Union Station in Washington, D.C., on Nov. 22, 2023. Ducharme is a contributor to TIME. A new variant of the virus that causes COVID-19 is ...
In early 2020, multisystemic inflammatory syndrome in children (MIS-C) was recognized as an emerging life-threatening disease occurring 2 to 6 weeks after infection with severe acute respiratory ...
As JN.1* gains prominence, understanding its unique characteristics and adapting public health strategies accordingly are paramount in mitigating the impact on global health. Fan, H., et al. (2024) ...
We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...
Background Although health problems may persist beyond 4 weeks after SARS-CoV-2 infection, evidence on long-term ophthalmic ...
Ensitrelvir represents a significant advancement in the treatment of COVID-19, setting the stage for enhanced defenses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results